Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 2, Février 2010
Page(s) 153 - 158
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010262153
Publié en ligne 15 février 2010
  1. Janoir C, Pechine S, Grosdidier C, et al. Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins. J Bacteriol 2007; 189 : 7174–80. [Google Scholar]
  2. Lyras D, O’Connor JR, Howarth PM, et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009; 458 : 1176–9. [Google Scholar]
  3. Jank T, Aktories K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol 2008; 16 : 222–9. [Google Scholar]
  4. Dupuy B, Govind R, Antunes A, et al. Clostridium difficile toxin synthesis is negatively regulated by TcdC. J Med Microbiol 2008; 57 : 685–9. [Google Scholar]
  5. Popoff MR, Rubin EJ, Gill DM, et al. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 1988; 56 : 2299–306. [Google Scholar]
  6. Carter GP, Lyras D, Allen DL, et al. Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol 2007; 189 : 7290–301. [Google Scholar]
  7. Barbut F, Decre D, Lalande V, et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 2005; 54 : 181–5. [Google Scholar]
  8. Kyne L, Warny M, Qamar A, et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342 : 390–7. [Google Scholar]
  9. Kyne L, Warny M, Qamar A, et al. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001; 357 : 189–93. [Google Scholar]
  10. Barbut F, Beaugerie L, Petit JC. Clostridium difficile et pathologie digestive. EMC (Elsevier Masson Paris), Maladies infectieuses 2008; 8–038–H–20. [Google Scholar]
  11. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320 : 204–10. [Google Scholar]
  12. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12 Suppl 6 : 2–18. [Google Scholar]
  13. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366 : 1079–84. [Google Scholar]
  14. Wilcox MH, Mooney L, Bendall R, et al. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008; 62 : 388–96. [Google Scholar]
  15. Beaugerie L, Flahault A, Barbut F, et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 2003; 17 : 905–12. [Google Scholar]
  16. Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47 : 1162–70. [Google Scholar]
  17. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008; 46 (suppl 1) : S12–8. [Google Scholar]
  18. Barbut F, Braun M, Burghoffer B, et al. Rapid diagnosis of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol 2009; 47 : 1276–7. [Google Scholar]
  19. Gerding DN, Muto CA, Owens RC Jr. Treatment of Clostridium difficile infection. Clin Infect Dis 2008; 46 (suppl 1) : S32–42. [Google Scholar]
  20. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45 : 302–7. [Google Scholar]
  21. McFarland LV. Renewed interest in a difficult disease. Clostridium difficile infections: epidemiology and current treatment strategies. Curr Opin Gastroenterol 2009; 25 : 24–35. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.